ReviewDrugs & aging2022
Benefit-Risk Assessment of Psychotropic Drugs in Older Patients with Chronic Obstructive Pulmonary Disease.
Abebaw Mengistu Yohannes et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it